Actively Recruiting
Comparing Depth of Focus Effects in Cataract Surgery for High Myopic Patients Using the NGENUITY 3D Visualization System Versus Traditional Optical Microscope
Led by National Taiwan University Hospital · Updated on 2025-07-02
45
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
N
National Taiwan University Hospital
Lead Sponsor
A
Alcon Research
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to compare surgical outcomes and parameters between cataract surgeries performed using a new 3D imaging system called the NGENUITY4 3D Visualization System and the current standard binocular microscope in patients with high myopia. The study focuses on how differences in depth of field between these two systems affect factors during surgery and the results, including potential complications. Participants will have high myopia and significant cataracts requiring surgery. Participants will be randomly assigned to one of two groups one group will undergo cataract surgery using the standard binocular microscope, while the other group will have surgery using the Alcon NGENUITY4 3D Visualization System. During surgery with the NGENUITY system, the surgeon wears 3D glasses and views the operation on a 3D screen. Both groups receive standard cataract extraction with phacoemulsification and intraocular lens implantation. Throughout the surgery, researchers will measure how often and how far the microscope focus is adjusted, the distance needed to focus from the corneal surface to the lens capsule, total operation time, and ultrasound energy used. After surgery, participants will be followed for three months to monitor vision, eye pressure, and any complications. These assessments will occur on day 1, week 1, month 1, and month 3 after surgery to evaluate safety and effectiveness of the two visualization methods.
CONDITIONS
Brief Title
3D Visualization System in Highly Myopic Cataract Operation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- High myopia with axial length of 26 millimeters or more
- Clinically significant age-related nuclear cataract requiring surgery, with LOC III NC/NO grade 3-5
- Participants aged 20 years or older
You will not qualify if you...
- Eye to be operated on has undergone vitrectomy surgery
- Eye to be operated on has undergone corneal refractive surgery
- Presence of corneal diseases affecting surgery clarity, such as dystrophy, trauma, scarring, ulcers, or softening
- Complicated cataracts with extreme hardness, zonular laxity, lens dislocation, extensive capsular fibrosis, or LOC III NO/NC6 or C4-C5 or P4-P5 classification
- Other non-myopia-related eye diseases significantly affecting surgery complexity, such as adhesive uveitis, corneal damage from trauma, intraocular inflammation adhesions, or severe uncorrected strabismus
Research Team
C
Cheng-Yung Lee, M.D.
T
Tzyy-Chang Ho, M.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here